Skip to main content
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc — Investor Relations & Filings

Ticker · JAZZ ISIN · USG508711052 US Manufacturing
Filings indexed 1,727 across all filing types
Latest filing 2026-04-24 Annual Report
Country US United States of America
Listing US JAZZ

About Jazz Pharmaceuticals plc

https://www.jazzpharma.com/

Jazz Pharmaceuticals is a global biopharmaceutical company that develops and commercializes medicines for patients with serious diseases, particularly those with limited or no therapeutic options. The company's portfolio and pipeline are concentrated in two primary therapeutic areas: oncology and neuroscience. It aims to address significant unmet medical needs by advancing novel therapies for complex conditions, including hematologic malignancies, solid tumors, sleep disorders, and treatment-resistant forms of epilepsy. The company's purpose is to innovate and transform the lives of patients by delivering life-changing treatments.

Recent filings

Filing Released Lang Actions
10-K/A - Jazz Pharmaceuticals plc (0001232524) (Filer)
Annual Report
2026-04-24 English
SCHEDULE 13G/A - Jazz Pharmaceuticals plc (0001232524) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - JAZZ PHARMACEUTICALS PLC (0001232524) (Filer)
Director's Dealing
2026-03-02 English
4 - JAZZ PHARMACEUTICALS PLC (0001232524) (Filer)
Director's Dealing
2026-03-02 English
4 - JAZZ PHARMACEUTICALS PLC (0001232524) (Filer)
Director's Dealing
2026-03-02 English
4 - JAZZ PHARMACEUTICALS PLC (0001232524) (Filer)
Director's Dealing
2026-03-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.